Search Results - "Arpicco, S."

Refine Results
  1. 1

    Uptake and intracellular distribution of different types of nanoparticles in primary human myoblasts and myotubes by Guglielmi, V., Carton, F., Vattemi, G., Arpicco, S., Stella, B., Berlier, G., Marengo, A., Boschi, F., Malatesta, M.

    Published in International journal of pharmaceutics (05-04-2019)
    “…[Display omitted] The use of nanoparticles as drug carriers in the field of skeletal muscle diseases has been poorly addressed and the interaction of…”
    Get full text
    Journal Article
  2. 2

    Selective delivery of pentamidine toward cancer cells by self-assembled nanoparticles by Andreana, I., Gazzano, E., Gianquinto, E., Piatti, G., Bincoletto, V., Kryza, D., Lollo, G., Spyrakis, F., Riganti, C., Arpicco, S., Stella, B.

    Published in International journal of pharmaceutics (25-09-2022)
    “…[Display omitted] •Pentamidine-loaded self-assembled biocompatible nanocarriers formed by ion-pairing.•The positively charged drug interacted with a negatively…”
    Get full text
    Journal Article
  3. 3

    Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery by Costanzo, M, Carton, F, Marengo, A, Berlier, G, Stella, B, Arpicco, S, Malatesta, M

    Published in European journal of histochemistry (14-04-2016)
    “…In order to design valid protocols for drug release via nanocarriers, it is essential to know the mechanisms of cell internalization, the interactions with…”
    Get full text
    Journal Article
  4. 4

    Characterization of chitosan thiolation and application to thiol quantification onto nanoparticle surface by Bravo-Osuna, I., Teutonico, D., Arpicco, S., Vauthier, C., Ponchel, G.

    Published in International journal of pharmaceutics (01-08-2007)
    “…The objective of the present work was to establish a simple and appropriated method for the quantification of thiol groups standing on the surface of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Hyaluronan-decorated liposomes as drug delivery systems for cutaneous administration by Franzé, Silvia, Marengo, Alessandro, Stella, Barbara, Minghetti, Paola, Arpicco, Silvia, Cilurzo, Francesco

    Published in International journal of pharmaceutics (15-01-2018)
    “…[Display omitted] The work aimed to evaluate the feasibility to design hyaluronic acid (HA) decorated flexible liposomes to enhance the skin penetration of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    (1280) Assessment of an Innovative Liposomal Preparations on Precision-Cut Lung Slices (PCLS): An Ex-Vivo Model of EMT by Bozzini, S., Bozza, E., Bagnera, C., Zoppa, M. Della, Lettieri, S., Bincoletto, V., Fante, C. Del, Stella, B., Briganti, F., Primiceri, C., Rinaldi, P., Baietto, G., Arpicco, S., Meloni, F.

    “…PCLS from lung resections or explants have gained increasing attention as novel human disease models and to overcome limitations of acellular scaffold models…”
    Get full text
    Journal Article
  9. 9

    Hyaluronic Acid Decorated-Liposome are Good Biocompatible Nano-Carrier for Drug Delivery to Mesenchymal Cells Derived from BAL of Bronchiolitis Obliterans Patients by Meloni, F., Pandolfi, L., Frangipane, V., Cova, E., Arpicco, S., Marengo, A., Bocca, C., Monti, M.

    “…Bronchiolitis Obliterans Syndrome (BOS), major clinical phenotype of chronic lung allograft dysfunction (CLAD), is responsible of poor long-term survival after…”
    Get full text
    Journal Article
  10. 10

    Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs by Immordino, Maria Laura, Brusa, Paola, Rocco, Flavio, Arpicco, Silvia, Ceruti, Maurizio, Cattel, Luigi

    Published in Journal of controlled release (10-12-2004)
    “…Gemcitabine is a known anticancer agent rapidly deaminated to the inactive metabolite 2′,2′-difluorodeoxyuridine; it must therefore be administered at very…”
    Get full text
    Journal Article
  11. 11

    Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel by Immordino, Maria Laura, Brusa, Paola, Arpicco, Silvia, Stella, Barbara, Dosio, Franco, Cattel, Luigi

    Published in Journal of controlled release (04-09-2003)
    “…The taxanes, paclitaxel and docetaxel, are anticancer agents used in clinical trials against ovarian carcinoma, breast, lung and head/neck cancer. Paclitaxel,…”
    Get full text
    Journal Article
  12. 12

    Design of folic acid-conjugated nanoparticles for drug targeting by Stella, B, Arpicco, S, Peracchia, M T, Desmaële, D, Hoebeke, J, Renoir, M, D'Angelo, J, Cattel, L, Couvreur, P

    Published in Journal of pharmaceutical sciences (01-11-2000)
    “…The new concept developed in this study is the design of poly(ethylene glycol) (PEG)-coated biodegradable nanoparticles coupled to folic acid to target the…”
    Get more information
    Journal Article
  13. 13

    Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes by Crosasso, Paola, Ceruti, Maurizio, Brusa, Paola, Arpicco, Silvia, Dosio, Franco, Cattel, Luigi

    Published in Journal of controlled release (03-01-2000)
    “…Paclitaxel (Taxol) is a diterpenoid isolated from Taxus brevifolia, approved by the FDA for the treatment of ovarian and breast cancers. Due to its low…”
    Get full text
    Journal Article
  14. 14

    In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody by Brusa, P, Dosio, F, Coppo, S, Pacchioni, D, Arpicco, S, Crosasso, P, Cattel, L

    Published in Farmaco (Società chimica italiana : 1989) (01-02-1997)
    “…5-Fluorouridine (5-FUr), a cytotoxic antitumoral agent not in clinical use because of its systemic toxicity, and AR-3, a monoclonal antibody specific to a…”
    Get more information
    Journal Article
  15. 15

    Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-κB into activated macrophages by De Rosa, Giuseppe, Stefano, Daniela De, Laguardia, Valeria, Arpicco, Silvia, Simeon, Vittorio, Carnuccio, Rosa, Fattal, Elias

    “…Nuclear factor-κB (NF-κB) is involved in several pathological processes, such as inflammation. Pro-inflammatory genes expression can be down-regulated by using…”
    Get full text
    Journal Article
  16. 16

    Therapeutic Potential of New 4-hydroxy-tamoxifen-Loaded pH-gradient Liposomes in a Multiple Myeloma Experimental Model by Urbinati, Giorgia, Audisio, Davide, Marsaud, Véronique, Plassat, Vincent, Arpicco, Silvia, Sola, Brigitte, Fattal, Elias, Renoir, Jack-Michel

    Published in Pharmaceutical research (01-02-2010)
    “…Purpose To determine the better liposomal formulation incorporating the active metabolite of tamoxifen, 4-hydroxy-tamoxifen (4HT) and the biological impact of…”
    Get full text
    Journal Article
  17. 17

    Biological characterization of folic acid-conjugated poly(H sub(2)NPEGCA-co-HDCA) nanoparticles in cellular models by Stella, B, Marsaud, V, Arpicco, S, Geraud, G, Cattel, L, Couvreur, P, Renoir, J-M

    Published in Journal of drug targeting (01-01-2007)
    “…The folate receptor (FR) is a highly selective tumor marker over expressed in many human cancers and it constitutes a useful target for tumor-specific drug…”
    Get full text
    Journal Article
  18. 18

    Poly(ethylene glycol)–human serum albumin–paclitaxel conjugates: preparation, characterization and pharmacokinetics by Dosio, Franco, Arpicco, Silvia, Brusa, Paola, Stella, Barbara, Cattel, Luigi

    Published in Journal of controlled release (11-09-2001)
    “…Paclitaxel has been found to be very effective against several human cancers, such as ovarian, breast and non-small cell lung cancer and has received marketing…”
    Get full text
    Journal Article
  19. 19

    Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel by Ceruti, Maurizio, Crosasso, Paola, Brusa, Paola, Arpicco, Silvia, Dosio, Franco, Cattel, Luigi

    Published in Journal of controlled release (03-01-2000)
    “…Paclitaxel (Taxol) is a diterpenoid isolated from Taxus brevifolia, used clinically for the treatment of ovarian and breast cancer. Due to its aqueous…”
    Get full text
    Journal Article
  20. 20

    Preparation, characterization and properties in vitro and in vivo of a paclitaxel–albumin conjugate by Dosio, Franco, Brusa, Paola, Crosasso, Paola, Arpicco, Silvia, Cattel, Luigi

    Published in Journal of controlled release (08-09-1997)
    “…Paclitaxel (taxol) is in routine clinical use for treatment of a variety of cancers. Because of its low aqueous solubility, it requires Cremophor EL…”
    Get full text
    Journal Article